Roche Overview
- Year Founded
-
1896
- Status
-
Public
- Employees
-
103,249
- Stock Symbol
-
ROG
- Investments
-
100
- Share Price
-
$350.80
- (As of Tuesday Closing)
Roche General Information
Description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact Information
Website
www.roche.comCorporate Office
- Konzern-Hauptsitz
- Grenzacherstrasse 124, Schweiz
- 4070 Basel
- Switzerland
Corporate Office
- Konzern-Hauptsitz
- Grenzacherstrasse 124, Schweiz
- 4070 Basel
- Switzerland
Roche Stock Performance
As of 18-Mar-2025, Roche’s stock price is $350.80. Its current market cap is $281B with 795M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $350.80 | $351.82 | $233.05 - $355.14 | $281B | 795M | 1.23M | $11.80 |
Roche Financials Summary
As of 31-Dec-2024, Roche has a trailing 12-month revenue of $70.9B.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 259,983,538 | 259,983,538 | 257,753,180 | 285,622,959 |
| Revenue | 70,862,341 | 70,862,341 | 67,237,351 | 68,927,453 |
| EBITDA | 18,579,005 | 18,579,005 | 20,407,823 | 21,777,699 |
| Net Income | 9,400,234 | 9,400,234 | 12,790,905 | 13,008,598 |
| Total Assets | 112,670,304 | 112,670,304 | 107,707,693 | 95,078,413 |
| Total Debt | 40,235,521 | 40,235,521 | 36,647,856 | 28,629,980 |
Roche Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Roche Comparisons
Industry
Financing
Details
Roche Competitors (30)
One of Roche’s 30 competitors is Biogen, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biogen | Formerly VC-backed | Cambridge, MA | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| Sanofi | Corporation | Paris, France | ||||
| Bolar Pharmaceuticals | Corporation | Lagos, Nigeria | ||||
| Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel |
Roche Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Roche Patents
Roche Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250085249-A1 | Differential output of analog memories storing nanopore measurement samples | Pending | 27-Nov-2024 | ||
| US-20250087330-A1 | Autonomous management of a diabetic condition based on mealtime and activity detection | Pending | 21-Nov-2024 | ||
| JP-2025026427-A | Anti-a-beta protein antibodies, methods and uses thereof | Pending | 09-Aug-2023 | ||
| EP-4489015-A1 | Methods and systems for meal event detection and medication bolus calculation | Pending | 07-Jul-2023 | ||
| EP-4488870-A1 | Computer implemented method for designing a complex part of an in-vitro diagnostic instrument | Pending | 03-Jul-2023 | G06F30/10 |
Roche Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Roche Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Roche Investments & Acquisitions (100)
Roche’s most recent deal was a Merger/Acquisition with Poseida Therapeutics for . The deal was made on 08-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Poseida Therapeutics | 08-Jan-2025 | Merger/Acquisition | Biotechnology | ||
| AntlerA | 25-Jul-2024 | Merger/Acquisition | Drug Discovery | ||
| Naru | 28-May-2024 | Accelerator/Incubator | Outcome Management (Healthcare) | ||
| Carmot Therapeutics | 26-Jan-2024 | Merger/Acquisition | Biotechnology | ||
| LumiraDx (Point of Care Diagnostics Platform Business) | 29-Dec-2023 | Merger/Acquisition | Other Healthcare Technology Systems |
Roche ESG
Risk Overview
Risk Rating
Updated July, 23, 2024
21.76 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,946
Rank
Percentile
Pharmaceuticals
Industry
of 847
Rank
Percentile
Pharmaceuticals
Subindustry
of 421
Rank
Percentile
Roche Exits (24)
Roche’s most recent exit was on 01-Dec-2021 from TIB Molbiol Syntheselabor. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| TIB Molbiol Syntheselabor | 01-Dec-2021 | Completed |
|
||
| Nimble Therapeutics | 11-Apr-2019 | Completed |
|
||
| Ariosa Diagnostics | 12-Jan-2015 | Completed |
|
||
| InterMune | 29-Sep-2014 | Completed |
|
||
| Allakos | 24-Sep-2014 | Early Stage VC | Completed |
|
Roche Affiliates
Subsidiaries (19)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Poseida Therapeutics | San Diego, CA | 2014 | |
| Spark Therapeutics | Philadelphia, PA | 2013 | |
| Flatiron | New York, NY | 2012 | |
| MySugr | Vienna, Austria | 2012 | |
| Foundation Medicine | Cambridge, MA | 2010 |
Roche FAQs
-
When was Roche founded?
Roche was founded in 1896.
-
Where is Roche headquartered?
Roche is headquartered in Basel, Switzerland.
-
What is the size of Roche?
Roche has 103,249 total employees.
-
What industry is Roche in?
Roche’s primary industry is Pharmaceuticals.
-
Is Roche a private or public company?
Roche is a Public company.
-
What is Roche’s stock symbol?
The ticker symbol for Roche is ROG.
-
What is the current stock price of Roche?
As of 18-Mar-2025 the stock price of Roche is $350.80.
-
What is the current market cap of Roche?
The current market capitalization of Roche is $281B.
-
What is Roche’s current revenue?
The trailing twelve month revenue for Roche is $70.9B.
-
Who are Roche’s competitors?
Biogen, AbbVie, Sanofi, Bolar Pharmaceuticals, and Teva Pharmaceutical Industries are some of the 30 competitors of Roche.
-
What is Roche’s annual earnings per share (EPS)?
Roche’s EPS for 12 months was $11.80.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
